April 25, 2019


En la esclerosis sistémica, el esófago se afecta en un 90%, seguido de los tramos anorrectal (%), gástrico ( 70%), colon (%) e intestino delgado. La esclerodermia es un relativamente infrecuente enfermedad reumática autoinmunitaria que afecta la piel y otros órganos del cuerpo. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.

Author: Shaktikazahn Nilrajas
Country: Tanzania
Language: English (Spanish)
Genre: Photos
Published (Last): 22 September 2015
Pages: 474
PDF File Size: 3.74 Mb
ePub File Size: 19.56 Mb
ISBN: 740-9-18604-652-3
Downloads: 92879
Price: Free* [*Free Regsitration Required]
Uploader: Kazragis

Raynaud’s phenomenon as side effect of beta-blockers in hypertension. Treprostinil for the treatment of severe digital necrosis in systemic sclerosis. Biomed Pharmacother, 50pp. J Rheumatol, 32pp. Lancet,pp. Disturbed right ventricular diastolic function in patients with systemic sclerosis: Pericardial tamponade in systemic sclerosis scleroderma.

Clin Exp Rheumatol, 18pp. Curr Rheumatol Rep, 6pp. Sixtemica J Dermatol,pp. J Rheumatol, 28pp. Rheumatology, 45pp.

There was a problem providing the content you requested

Echocardiographic alterations in systemic sclerosis: Rheumatology, 42pp. Iloprost for severe Raynaud’s phenomenon and ischemic ulcers related with systemic diseases. Clinical manifestations include dyspnea, palpitations, chest pain, syncope, and symptoms of right heart failure. Intravenous N-Acetylcysteine for treatment of Raynaud’s secondary to systemic sclerosis: Assessment of vascular function in systemic sclerosis: Recombinant human relaxin in the treatment of scleroderma.


Hemorragia por telangiectasias en paciente con esclerosis sistémica

Ann Intern Med, 97pp. Hemopoietic stem cell transplantation in rheumatic diseases —an update. Sildenafil in the treatment of Raynaud’s phenomenon resistant to vasodilator therapy. Nailfold digital capillaroscopy in patients with connective tissue disease and Raynaud’s disease. Double-blind, multicenter controlled trial comparing topical dimethyl sulfoxide and normal saline for treatment of hand ulcers in patients with systemic sclerosis. Left sietemica diastolic function in systemic sclerosis.

Br J Rheumatol, 37pp. Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Management of Raynaud’s phenomenon and digital ischemic lesions in scleroderma.

Arteries of the hand in patients with scleroderma. Scleroderma complicated with tamponade during pregnancy. Reumatismo, 59pp. Ann Rheum Dis, 66pp.

Úlceras digitales en la esclerosis sistémica | Seminarios de la Fundación Española de Reumatología

Rheumatology, 43pp. Case report A 50 year old male, with no relevant family sistemuca, who was diagnosed of subclinical hypothyroidism and early scleroderma has been follow-up by Rheumatology and Dermatology. Treatment of systemic sclerosis by potentially disease-modifying drugs.


Serotonin reuptake inhibitors in Raynaud’s phenomenon. Noninvasive assessment of sistrmica involvement in patients with systemic sclerosis: Arthritis Rheum, 44pp. Angiology, 45pp.

Severe refractory fingertip ulcerations in a patient with scleroderma: N Engl J Med,pp. Medicine, 59pp. Rev Med Suisse Romande,pp. Scleroderma is a disease characterized by multiorgan fibrosis due to connective esclerksis proliferation and vasculitis of small vessels. Subjective and objective assessment of enalapril in primary Raynaud’s phenomenon. Ulnar artery involvement in systemic sclerosis. Ann Rheum Dis, 59pp.

Clin Rheumatol, 21pp. Giusti De Marle, A. Arthritis Rheum, 48pp. Endothelial siistemica apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD The knowledge of the pathogenesis of systemic sclerosis to molecular level will lead to new treatment strategies. The influence of different beta-blocking drugs on the peripheral circulation in Raynaud phenomenon and in hypertension.